Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1, Double-Blind, Placebo-Controlled Assessment of Potential Interactions Between Intravenous Cocaine and Clavulanic Acid

NCT02563769 is registered in ClinicalTrials.gov with Temple University as lead sponsor.

NCT NCT02563769
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02563769 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1, Double-Blind, Placebo-Controlled Assessment of Potential Interactions Between Intravenous Cocaine and Clavulanic Acid
Lead sponsor
Temple University
Phase
Phase 1
Overall status
Completed
Start date
October 24, 2016
Completion date
May 25, 2018
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cocaine abuse, cocaine addiction, cocaine dependence, cocaine-related disorders